AIM ImmunoTech (AIM) Return on Equity [ROE] (2011 - 2026)
AIM ImmunoTech's Return on Equity [ROE] came in at -248.78% for Q2 2026.
Powered by 
Analysis
AIM ImmunoTech (AIM) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2024, AIM ImmunoTech's Return on Equity [ROE] was -456.84%, down 325.78 percentage points from FY2023.
- Return on Equity [ROE] has declined in each of the last three years, with a five-year change of -320.82 percentage points (FY2019 to FY2024).
- Going back by year, Return on Equity [ROE] was -131.07% in FY2023 (-89.28 pp), -41.79% in FY2022 (-9.76 pp), -32.03% in FY2021 (+10.48 pp) and -42.51% in FY2020 (+93.51 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q4 2023.
- Across the past five years, year-over-year drop in Return on Equity [ROE] ran from 0.92 percentage points in Q3 2021 to 2366.23 percentage points in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 4.97% |
| 10 | AIM ImmunoTech | 3.25 Mn | -18.05 Mn | 21,000.00 | -248.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -248.78% |
| Dec 31, 2024 | -2,560.63% |
| Sep 30, 2024 | -629.55% |
| Jun 30, 2024 | -582.72% |
| Mar 31, 2024 | -443.93% |
| Dec 31, 2023 | -194.40% |
| Sep 30, 2023 | -89.00% |
| Jun 30, 2023 | -67.05% |
| Mar 31, 2023 | -57.14% |
| Dec 31, 2022 | -48.79% |
| Sep 30, 2022 | -47.32% |
| Jun 30, 2022 | -37.36% |
| Mar 31, 2022 | -33.02% |
| Dec 31, 2021 | -31.65% |
| Sep 30, 2021 | -26.09% |
| Jun 30, 2021 | -23.51% |
| Mar 31, 2021 | -24.06% |
| Dec 31, 2020 | -25.88% |
| Sep 30, 2020 | -25.16% |
| Jun 30, 2020 | -33.23% |
API Access
AIM ImmunoTech Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AIM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AIM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AIM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();